Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $6.68, $0.28 better than the analyst estimate of $6.40. Revenue for the quarter came in at $12.14 billion versus the consensus estimate of $11.95 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.